Runx2 Association with Progression of Prostate Cancer in Patients: Mechanisms Mediating Bone Osteolysis and Osteoblastic Metastatic Lesions

Runx2, a bone-specific transcriptional regulator, is abnormally expressed in highly metastatic prostate cancer cells. Here we identified the functional activities of Runx2 in facilitating tumor growth and osteolysis. Our studies demonstrate that negligible Runx2 is found in normal prostate epithelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Akech, Jacqueline, Wixted, John J., Bedard, Krystin, van der Deen, Margaretha, Hussain, Sadiq, Guise, Theresa A., van Wijnen, Andre J., Stein, Janet L., Languino, Lucia R., Altieri, Dario C., Pratap, Jitesh, Keller, Evan, Stein, Gary S., Lian, Jane B.
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820596/
https://www.ncbi.nlm.nih.gov/pubmed/19915614
http://dx.doi.org/10.1038/onc.2009.389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820596/
https://www.ncbi.nlm.nih.gov/pubmed/19915614
http://dx.doi.org/10.1038/onc.2009.389

Ejemplares similares